(-0.08%) 5 031.82 points
(0.40%) 37 969 points
(-0.01%) 15 656 points
(-3.61%) $78.97
(-2.46%) $1.942
(0.31%) $2 310.00
(0.89%) $26.89
(1.11%) $958.75
(-0.21%) $0.935
(-0.27%) $11.07
(-0.13%) $0.799
(-0.48%) $93.00
2.49% $ 3.29
@ $4.87
Emitido: 14 feb 2024 @ 13:51
Retorno: -32.44%
Señal anterior: feb 14 - 09:33
Señal anterior:
Retorno: -1.22 %
Live Chart Being Loaded With Signals
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy...
Stats | |
---|---|
Volumen de hoy | 269 529 |
Volumen promedio | 834 395 |
Capitalización de mercado | 172.80M |
EPS | $0 ( 2024-03-28 ) |
Próxima fecha de ganancias | ( $-1.090 ) 2024-05-20 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.660 |
ATR14 | $0.00700 (0.21%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-06-30 | Baker Bros. Advisors Lp | Buy | 40 000 | Non-Qualified Stock Options (right to buy) |
2023-06-30 | Yang Taiyin | Buy | 40 000 | Stock Option (Right to Buy) |
2023-06-30 | Profusek Robert | Buy | 40 000 | Stock Option (Right to Buy) |
2023-06-30 | Levy Richard S | Buy | 40 000 | Stock Option (Right to Buy) |
2023-06-30 | Dahiyat Bassil I | Buy | 40 000 | Stock Option (Right to Buy) |
INSIDER POWER |
---|
96.05 |
Last 99 transactions |
Buy: 3 824 931 | Sell: 1 385 823 |
Volumen Correlación
Kodiak Sciences Inc Correlación
10 Correlaciones Más Positivas | |
---|---|
SONN | 0.914 |
VERU | 0.908 |
VNET | 0.908 |
INFI | 0.906 |
DZSI | 0.903 |
LIVN | 0.902 |
TCX | 0.902 |
RYTM | 0.901 |
PCVX | 0.899 |
FNWB | 0.897 |
10 Correlaciones Más Negativas | |
---|---|
TYHT | -0.933 |
AAON | -0.913 |
GSHD | -0.912 |
PLPC | -0.905 |
ZGNX | -0.903 |
CNCE | -0.901 |
LNTH | -0.9 |
CPTA | -0.897 |
LMNR | -0.895 |
ADMS | -0.893 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kodiak Sciences Inc Correlación - Moneda/Commodity
Kodiak Sciences Inc Finanzas
Annual | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-25.95M (0.00 %) |
EPS: | $-4.97 |
FY | 2023 |
Ingresos: | $0 |
Beneficio Bruto: | $-25.95M (0.00 %) |
EPS: | $-4.97 |
FY | 2022 |
Ingresos: | $0 |
Beneficio Bruto: | $-11.00M (0.00 %) |
EPS: | $6 502.21 |
FY | 2021 |
Ingresos: | $0.00 |
Beneficio Bruto: | $0.00 (0.00 %) |
EPS: | $-5.16 |
Financial Reports:
No articles found.
Kodiak Sciences Inc
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet inhibitor for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Acerca de Señales en Vivo
Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.
Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico